1 Market Overview

1.1 Product Overview and Scope of Treatment and Prevention of Herpes Labialis

1.2 Classification of Treatment and Prevention of Herpes Labialis by Type

1.2.1 Overview: Global Treatment and Prevention of Herpes Labialis Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type in 2021

1.2.3 Valacyclovir

1.2.4 Aciclovir

1.2.5 Famciclovir

1.2.6 Docosanol

1.2.7 Other

1.3 Global Treatment and Prevention of Herpes Labialis Market by Application

1.3.1 Overview: Global Treatment and Prevention of Herpes Labialis Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 External Use

1.3.3 Oral

1.3.4 Injection

1.4 Global Treatment and Prevention of Herpes Labialis Market Size & Forecast

1.5 Global Treatment and Prevention of Herpes Labialis Market Size and Forecast by Region

1.5.1 Global Treatment and Prevention of Herpes Labialis Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Treatment and Prevention of Herpes Labialis Market Size by Region, (2017-2022)

1.5.3 North America Treatment and Prevention of Herpes Labialis Market Size and Prospect (2017-2028)

1.5.4 Europe Treatment and Prevention of Herpes Labialis Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size and Prospect (2017-2028)

1.5.6 South America Treatment and Prevention of Herpes Labialis Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Treatment and Prevention of Herpes Labialis Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Treatment and Prevention of Herpes Labialis Market Drivers

1.6.2 Treatment and Prevention of Herpes Labialis Market Restraints

1.6.3 Treatment and Prevention of Herpes Labialis Trends Analysis

2 Company Profiles

2.1 GSK

2.1.1 GSK Details

2.1.2 GSK Major Business

2.1.3 GSK Treatment and Prevention of Herpes Labialis Product and Solutions

2.1.4 GSK Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 GSK Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis Treatment and Prevention of Herpes Labialis Product and Solutions

2.2.4 Novartis Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Novartis Recent Developments and Future Plans

2.3 Teva

2.3.1 Teva Details

2.3.2 Teva Major Business

2.3.3 Teva Treatment and Prevention of Herpes Labialis Product and Solutions

2.3.4 Teva Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Teva Recent Developments and Future Plans

2.4 Mylan

2.4.1 Mylan Details

2.4.2 Mylan Major Business

2.4.3 Mylan Treatment and Prevention of Herpes Labialis Product and Solutions

2.4.4 Mylan Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Mylan Recent Developments and Future Plans

2.5 Cadila

2.5.1 Cadila Details

2.5.2 Cadila Major Business

2.5.3 Cadila Treatment and Prevention of Herpes Labialis Product and Solutions

2.5.4 Cadila Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Cadila Recent Developments and Future Plans

2.6 Apotex

2.6.1 Apotex Details

2.6.2 Apotex Major Business

2.6.3 Apotex Treatment and Prevention of Herpes Labialis Product and Solutions

2.6.4 Apotex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Apotex Recent Developments and Future Plans

2.7 Daewoong Pharmaceutical

2.7.1 Daewoong Pharmaceutical Details

2.7.2 Daewoong Pharmaceutical Major Business

2.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product and Solutions

2.7.4 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Daewoong Pharmaceutical Recent Developments and Future Plans

2.8 Livzon

2.8.1 Livzon Details

2.8.2 Livzon Major Business

2.8.3 Livzon Treatment and Prevention of Herpes Labialis Product and Solutions

2.8.4 Livzon Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Livzon Recent Developments and Future Plans

2.9 Luoxin

2.9.1 Luoxin Details

2.9.2 Luoxin Major Business

2.9.3 Luoxin Treatment and Prevention of Herpes Labialis Product and Solutions

2.9.4 Luoxin Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Luoxin Recent Developments and Future Plans

2.10 Med shine

2.10.1 Med shine Details

2.10.2 Med shine Major Business

2.10.3 Med shine Treatment and Prevention of Herpes Labialis Product and Solutions

2.10.4 Med shine Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Med shine Recent Developments and Future Plans

2.11 Bayer(Campho Phenique)

2.11.1 Bayer(Campho Phenique) Details

2.11.2 Bayer(Campho Phenique) Major Business

2.11.3 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Product and Solutions

2.11.4 Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Bayer(Campho Phenique) Recent Developments and Future Plans

2.12 Blistex

2.12.1 Blistex Details

2.12.2 Blistex Major Business

2.12.3 Blistex Treatment and Prevention of Herpes Labialis Product and Solutions

2.12.4 Blistex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Blistex Recent Developments and Future Plans

2.13 Kelun Group

2.13.1 Kelun Group Details

2.13.2 Kelun Group Major Business

2.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Product and Solutions

2.13.4 Kelun Group Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Kelun Group Recent Developments and Future Plans

2.14 Hikma

2.14.1 Hikma Details

2.14.2 Hikma Major Business

2.14.3 Hikma Treatment and Prevention of Herpes Labialis Product and Solutions

2.14.4 Hikma Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Hikma Recent Developments and Future Plans

2.15 Haiwang

2.15.1 Haiwang Details

2.15.2 Haiwang Major Business

2.15.3 Haiwang Treatment and Prevention of Herpes Labialis Product and Solutions

2.15.4 Haiwang Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Haiwang Recent Developments and Future Plans

2.16 Carmex

2.16.1 Carmex Details

2.16.2 Carmex Major Business

2.16.3 Carmex Treatment and Prevention of Herpes Labialis Product and Solutions

2.16.4 Carmex Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Carmex Recent Developments and Future Plans

2.17 Cipher

2.17.1 Cipher Details

2.17.2 Cipher Major Business

2.17.3 Cipher Treatment and Prevention of Herpes Labialis Product and Solutions

2.17.4 Cipher Treatment and Prevention of Herpes Labialis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Cipher Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Treatment and Prevention of Herpes Labialis Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Treatment and Prevention of Herpes Labialis Players Market Share in 2021

3.2.2 Top 10 Treatment and Prevention of Herpes Labialis Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Treatment and Prevention of Herpes Labialis Players Head Office, Products and Services Provided

3.4 Treatment and Prevention of Herpes Labialis Mergers & Acquisitions

3.5 Treatment and Prevention of Herpes Labialis New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Treatment and Prevention of Herpes Labialis Revenue and Market Share by Type (2017-2022)

4.2 Global Treatment and Prevention of Herpes Labialis Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Application (2017-2022)

5.2 Global Treatment and Prevention of Herpes Labialis Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2028)

6.2 North America Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2028)

6.3 North America Treatment and Prevention of Herpes Labialis Market Size by Country

6.3.1 North America Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2028)

6.3.2 United States Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

6.3.3 Canada Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

6.3.4 Mexico Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2028)

7.2 Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2028)

7.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Country

7.3.1 Europe Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2028)

7.3.2 Germany Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

7.3.3 France Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

7.3.5 Russia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

7.3.6 Italy Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2028)

8.2 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2028)

8.3 Asia-Pacific Treatment and Prevention of Herpes Labialis Market Size by Region

8.3.1 Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Region (2017-2028)

8.3.2 China Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

8.3.3 Japan Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

8.3.4 South Korea Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

8.3.5 India Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

8.3.7 Australia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2028)

9.2 South America Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2028)

9.3 South America Treatment and Prevention of Herpes Labialis Market Size by Country

9.3.1 South America Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2028)

9.3.2 Brazil Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

9.3.3 Argentina Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2028)

10.2 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2028)

10.3 Middle East & Africa Treatment and Prevention of Herpes Labialis Market Size by Country

10.3.1 Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2028)

10.3.2 Turkey Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

10.3.4 UAE Treatment and Prevention of Herpes Labialis Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Treatment and Prevention of Herpes Labialis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Treatment and Prevention of Herpes Labialis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Treatment and Prevention of Herpes Labialis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Region (2017-2022)

Table 5. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Region (2023-2028)

Table 6. GSK Corporate Information, Head Office, and Major Competitors

Table 7. GSK Major Business

Table 8. GSK Treatment and Prevention of Herpes Labialis Product and Solutions

Table 9. GSK Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Novartis Corporate Information, Head Office, and Major Competitors

Table 11. Novartis Major Business

Table 12. Novartis Treatment and Prevention of Herpes Labialis Product and Solutions

Table 13. Novartis Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Teva Corporate Information, Head Office, and Major Competitors

Table 15. Teva Major Business

Table 16. Teva Treatment and Prevention of Herpes Labialis Product and Solutions

Table 17. Teva Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Mylan Corporate Information, Head Office, and Major Competitors

Table 19. Mylan Major Business

Table 20. Mylan Treatment and Prevention of Herpes Labialis Product and Solutions

Table 21. Mylan Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Cadila Corporate Information, Head Office, and Major Competitors

Table 23. Cadila Major Business

Table 24. Cadila Treatment and Prevention of Herpes Labialis Product and Solutions

Table 25. Cadila Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Apotex Corporate Information, Head Office, and Major Competitors

Table 27. Apotex Major Business

Table 28. Apotex Treatment and Prevention of Herpes Labialis Product and Solutions

Table 29. Apotex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Daewoong Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 31. Daewoong Pharmaceutical Major Business

Table 32. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Product and Solutions

Table 33. Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Livzon Corporate Information, Head Office, and Major Competitors

Table 35. Livzon Major Business

Table 36. Livzon Treatment and Prevention of Herpes Labialis Product and Solutions

Table 37. Livzon Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Luoxin Corporate Information, Head Office, and Major Competitors

Table 39. Luoxin Major Business

Table 40. Luoxin Treatment and Prevention of Herpes Labialis Product and Solutions

Table 41. Luoxin Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Med shine Corporate Information, Head Office, and Major Competitors

Table 43. Med shine Major Business

Table 44. Med shine Treatment and Prevention of Herpes Labialis Product and Solutions

Table 45. Med shine Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Bayer(Campho Phenique) Corporate Information, Head Office, and Major Competitors

Table 47. Bayer(Campho Phenique) Major Business

Table 48. Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Product and Solutions

Table 49. Bayer(Campho Phenique) Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Blistex Corporate Information, Head Office, and Major Competitors

Table 51. Blistex Major Business

Table 52. Blistex Treatment and Prevention of Herpes Labialis Product and Solutions

Table 53. Blistex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Kelun Group Corporate Information, Head Office, and Major Competitors

Table 55. Kelun Group Major Business

Table 56. Kelun Group Treatment and Prevention of Herpes Labialis Product and Solutions

Table 57. Kelun Group Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Hikma Corporate Information, Head Office, and Major Competitors

Table 59. Hikma Major Business

Table 60. Hikma Treatment and Prevention of Herpes Labialis Product and Solutions

Table 61. Hikma Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Haiwang Corporate Information, Head Office, and Major Competitors

Table 63. Haiwang Major Business

Table 64. Haiwang Treatment and Prevention of Herpes Labialis Product and Solutions

Table 65. Haiwang Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Carmex Corporate Information, Head Office, and Major Competitors

Table 67. Carmex Major Business

Table 68. Carmex Treatment and Prevention of Herpes Labialis Product and Solutions

Table 69. Carmex Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Cipher Corporate Information, Head Office, and Major Competitors

Table 71. Cipher Major Business

Table 72. Cipher Treatment and Prevention of Herpes Labialis Product and Solutions

Table 73. Cipher Treatment and Prevention of Herpes Labialis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 75. Global Treatment and Prevention of Herpes Labialis Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 76. Breakdown of Treatment and Prevention of Herpes Labialis by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Treatment and Prevention of Herpes Labialis Players Head Office, Products and Services Provided

Table 78. Treatment and Prevention of Herpes Labialis Mergers & Acquisitions in the Past Five Years

Table 79. Treatment and Prevention of Herpes Labialis New Entrants and Expansion Plans

Table 80. Global Treatment and Prevention of Herpes Labialis Revenue (USD Million) by Type (2017-2022)

Table 81. Global Treatment and Prevention of Herpes Labialis Revenue Share by Type (2017-2022)

Table 82. Global Treatment and Prevention of Herpes Labialis Revenue Forecast by Type (2023-2028)

Table 83. Global Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2022)

Table 84. Global Treatment and Prevention of Herpes Labialis Revenue Forecast by Application (2023-2028)

Table 85. North America Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2022) & (USD Million)

Table 86. North America Treatment and Prevention of Herpes Labialis Revenue by Type (2023-2028) & (USD Million)

Table 87. North America Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2022) & (USD Million)

Table 88. North America Treatment and Prevention of Herpes Labialis Revenue by Application (2023-2028) & (USD Million)

Table 89. North America Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2022) & (USD Million)

Table 90. North America Treatment and Prevention of Herpes Labialis Revenue by Country (2023-2028) & (USD Million)

Table 91. Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2022) & (USD Million)

Table 92. Europe Treatment and Prevention of Herpes Labialis Revenue by Type (2023-2028) & (USD Million)

Table 93. Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2022) & (USD Million)

Table 94. Europe Treatment and Prevention of Herpes Labialis Revenue by Application (2023-2028) & (USD Million)

Table 95. Europe Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2022) & (USD Million)

Table 96. Europe Treatment and Prevention of Herpes Labialis Revenue by Country (2023-2028) & (USD Million)

Table 97. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2022) & (USD Million)

Table 98. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Type (2023-2028) & (USD Million)

Table 99. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2022) & (USD Million)

Table 100. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Application (2023-2028) & (USD Million)

Table 101. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Region (2017-2022) & (USD Million)

Table 102. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue by Region (2023-2028) & (USD Million)

Table 103. South America Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2022) & (USD Million)

Table 104. South America Treatment and Prevention of Herpes Labialis Revenue by Type (2023-2028) & (USD Million)

Table 105. South America Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2022) & (USD Million)

Table 106. South America Treatment and Prevention of Herpes Labialis Revenue by Application (2023-2028) & (USD Million)

Table 107. South America Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2022) & (USD Million)

Table 108. South America Treatment and Prevention of Herpes Labialis Revenue by Country (2023-2028) & (USD Million)

Table 109. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2017-2022) & (USD Million)

Table 110. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Type (2023-2028) & (USD Million)

Table 111. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2017-2022) & (USD Million)

Table 112. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Application (2023-2028) & (USD Million)

Table 113. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Country (2017-2022) & (USD Million)

Table 114. Middle East & Africa Treatment and Prevention of Herpes Labialis Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Treatment and Prevention of Herpes Labialis Picture

Figure 2. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type in 2021

Figure 3. Valacyclovir

Figure 4. Aciclovir

Figure 5. Famciclovir

Figure 6. Docosanol

Figure 7. Other

Figure 8. Treatment and Prevention of Herpes Labialis Revenue Market Share by Application in 2021

Figure 9. External Use Picture

Figure 10. Oral Picture

Figure 11. Injection Picture

Figure 12. Global Treatment and Prevention of Herpes Labialis Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Treatment and Prevention of Herpes Labialis Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Region (2017-2028)

Figure 15. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Region in 2021

Figure 16. North America Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Treatment and Prevention of Herpes Labialis Market Drivers

Figure 22. Treatment and Prevention of Herpes Labialis Market Restraints

Figure 23. Treatment and Prevention of Herpes Labialis Market Trends

Figure 24. GSK Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. Teva Recent Developments and Future Plans

Figure 27. Mylan Recent Developments and Future Plans

Figure 28. Cadila Recent Developments and Future Plans

Figure 29. Apotex Recent Developments and Future Plans

Figure 30. Daewoong Pharmaceutical Recent Developments and Future Plans

Figure 31. Livzon Recent Developments and Future Plans

Figure 32. Luoxin Recent Developments and Future Plans

Figure 33. Med shine Recent Developments and Future Plans

Figure 34. Bayer(Campho Phenique) Recent Developments and Future Plans

Figure 35. Blistex Recent Developments and Future Plans

Figure 36. Kelun Group Recent Developments and Future Plans

Figure 37. Hikma Recent Developments and Future Plans

Figure 38. Haiwang Recent Developments and Future Plans

Figure 39. Carmex Recent Developments and Future Plans

Figure 40. Cipher Recent Developments and Future Plans

Figure 41. Global Treatment and Prevention of Herpes Labialis Revenue Share by Players in 2021

Figure 42. Treatment and Prevention of Herpes Labialis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 43. Global Top 3 Players Treatment and Prevention of Herpes Labialis Revenue Market Share in 2021

Figure 44. Global Top 10 Players Treatment and Prevention of Herpes Labialis Revenue Market Share in 2021

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 46. Global Treatment and Prevention of Herpes Labialis Revenue Share by Type in 2021

Figure 47. Global Treatment and Prevention of Herpes Labialis Market Share Forecast by Type (2023-2028)

Figure 48. Global Treatment and Prevention of Herpes Labialis Revenue Share by Application in 2021

Figure 49. Global Treatment and Prevention of Herpes Labialis Market Share Forecast by Application (2023-2028)

Figure 50. North America Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2017-2028)

Figure 51. North America Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2017-2028)

Figure 52. North America Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2017-2028)

Figure 53. United States Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Canada Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Mexico Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Europe Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2017-2028)

Figure 57. Europe Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2017-2028)

Figure 58. Europe Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2017-2028)

Figure 59. Germany Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. France Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. United Kingdom Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Russia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Italy Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Asia-Pacific Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2017-2028)

Figure 65. Asia-Pacific Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2017-2028)

Figure 66. Asia-Pacific Treatment and Prevention of Herpes Labialis Revenue Market Share by Region (2017-2028)

Figure 67. China Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Japan Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South Korea Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. India Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Southeast Asia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Australia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South America Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2017-2028)

Figure 74. South America Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2017-2028)

Figure 75. South America Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2017-2028)

Figure 76. Brazil Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Argentina Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Middle East and Africa Treatment and Prevention of Herpes Labialis Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Treatment and Prevention of Herpes Labialis Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Treatment and Prevention of Herpes Labialis Revenue Market Share by Country (2017-2028)

Figure 81. Turkey Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Saudi Arabia Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. UAE Treatment and Prevention of Herpes Labialis Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source